MMUT (P22033) variants and mutations
MMUT (also known as P22033) is a human protein-coding gene encoding a methylmalonyl-CoA mutase, mitochondrial protein. It converts methylmalonyl-CoA to succinyl-CoA in mitochondria using adenosylcobalamin as a cofactor. Biallelic loss-of-function variants cause isolated methylmalonic acidemia, which can lead to metabolic acidosis, hyperammonemia, neurologic injury, and chronic kidney disease. This analysis covers 1,295 MMUT variants and mutations. Of these, 77% have computational variant effect predictions. Disease context includes methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, vitamin B12-unresponsive methylmalonic acidemia type mut0, and methylmalonic acidemia. Example MMUT variants include M1T, L2F, and R3*.
Variant analysis overview
- Gene: MMUT
- Protein: P22033
- UniProt accession: P22033
- Organism: Homo sapiens
- Variants analyzed: 1295
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 1,076 unspecified-consequence records; 1 stop retained variant; 85 synonymous variants; 105 missense variants; 22 frameshift variants; 2 in-frame insertions; 3 splice-region variants; 1 stop-gained variants; 1 in-frame deletions; 1 substitution
- Prediction scores: 995 variants have prediction scores (77% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, vitamin B12-unresponsive methylmalonic acidemia type mut0, methylmalonic acidemia, vitamin B12-unresponsive methylmalonic acidemia type mut, Methylmalonic aciduria, Abnormality of metabolism/homeostasis, Vitamin B12-responsive methylmalonic acidemia type cblB, neonatal encephalopathy, vitamin B deficiency, acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, diabetes mellitus, vitamin B12 deficiency.
Protein structure and variant hotspots
- Protein features: 1 domains; 9 binding sites; 7 post-translational modification sites.
- Structural context: 326 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable MMUT variants
Examples include M1T, L2F, R3*, R3K, K5N, N6K, N6S, Q7*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1T (p.Met1Thr), rs879253820, ClinGen CA10575890, ClinVar RCV000236350, ClinVar RCV000714689, MutPred 1.00, Pathogenic, METHYLMALONIC ACIDURIA, mut(0) TYPE; Methylmalonic aciduria due to methylmalonyl
- L2F (p.Leu2Phe), NCI-TCGA Cosmic COSV5128, Variant assessed as somatic; moderate impact.
- R3* (p.Arg3Ter), rs750583669, ClinGen CA3847195, ClinVar RCV001257406, ExAC rs750583669, CADD 36.00, Likely pathogenic
- R3K (p.Arg3Lys), TOPMed rs1767783379, REVEL 0.36, CADD 22.20
- K5N (p.Lys5Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N6K (p.Asn6Lys), ExAC rs765259599, REVEL 0.24, CADD 12.40
- N6S (p.Asn6Ser), TOPMed rs1049797121, gnomAD rs1049797121, REVEL 0.25, CADD 9.47
- Q7* (p.Gln7Ter), rs761773115, ClinGen CA347859, ClinVar RCV000203322, ClinVar RCV001293610, MutPred 0.21, Pathogenic
- Q7E (p.Gln7Glu), ExAC rs761773115, TOPMed rs761773115, gnomAD rs761773115, REVEL 0.21, CADD 13.30, Pathogenic
- Q7R (p.Gln7Arg), ExAC rs776721240, gnomAD rs776721240, REVEL 0.27, CADD 2.11
- L8F (p.Leu8Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L8V (p.Leu8Val), TOPMed rs1767782843, REVEL 0.26, CADD 17.90
- F9L (p.Phe9Leu), gnomAD rs1199433542, REVEL 0.32, CADD 12.50
- L11P (p.Leu11Pro), rs763898170, ClinGen CA3847192, ClinVar RCV002634149, ExAC rs763898170, REVEL 0.58, CADD 17.30, Uncertain significance
- S12* (p.Ser12Ter), ExAC rs775177090, gnomAD rs775177090, CADD 33.00, Uncertain significance
- S12L (p.Ser12Leu), ExAC rs775177090, gnomAD rs775177090, REVEL 0.31, CADD 16.20, Uncertain significance, not specified
- P13L (p.Pro13Leu), rs1057518979, ClinGen CA16043606, ClinVar RCV000414778, TOPMed rs1057518979, REVEL 0.38, CADD 20.70, Uncertain significance, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- P13S (p.Pro13Ser), ExAC rs771672322, gnomAD rs771672322, REVEL 0.34, CADD 20.60, Uncertain significance, not provided
- H14D (p.His14Asp), ExAC rs745369199, gnomAD rs745369199, Uncertain significance
- H14L (p.His14Leu), rs886061561, ClinGen CA10627106, ClinVar RCV000670305, TOPMed rs886061561, REVEL 0.27, CADD 21.20, Uncertain significance, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- H14N (p.His14Asn), ExAC rs745369199, gnomAD rs745369199, REVEL 0.21, CADD 16.30, Uncertain significance
- H14Q (p.His14Gln), TOPMed rs1767781874, gnomAD rs1767781874, REVEL 0.28, CADD 15.80
- H14R (p.His14Arg), TOPMed rs886061561, gnomAD rs886061561, REVEL 0.24, CADD 18.70, Uncertain significance
- H14Y (p.His14Tyr), rs745369199, ClinGen CA364405952, NCI-TCGA Cosmic COSV5127, NCI-TCGA Cosmic COSV9922, MutPred 0.22, Uncertain significance
- Y15N (p.Tyr15Asn), gnomAD rs1379493579
- L16V (p.Leu16Val), rs773920536, ClinGen CA3847187, ClinVar RCV004475334, ExAC rs773920536, REVEL 0.28, CADD 11.00, Uncertain significance, not specified
- R17K (p.Arg17Lys), TOPMed rs1021794777
- R17S (p.Arg17Ser), gnomAD rs1446591628, REVEL 0.25, CADD 13.30
- Q18* (p.Gln18Ter), rs121918248, ClinGen CA249725, ClinVar RCV000001954, ClinVar RCV000203362, CADD 33.00, Pathogenic
- Q18R (p.Gln18Arg), rs372601759, ClinGen CA3847186, ClinVar RCV001243259, ClinVar RCV001835161, REVEL 0.24, CADD 13.80, Uncertain significance, not provided
- V19G (p.Val19Gly), ExAC rs781576538, gnomAD rs781576538
- K20E (p.Lys20Glu), gnomAD rs1162806734
- K20R (p.Lys20Arg), Ensembl rs1767780995
- E21* (p.Glu21Ter), rs1767780776, ClinGen CA364405880, NCI-TCGA Cosmic COSV9922, ClinVar RCV001198995, Likely pathogenic
- E21A (p.Glu21Ala), 1000Genomes rs577356836, ExAC rs577356836, gnomAD rs577356836, REVEL 0.31, CADD 2.15
- S22* (p.Ser22Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S22L (p.Ser22Leu), rs780304897, ClinGen CA3847182, ClinVar RCV004475364, ExAC rs780304897, REVEL 0.25, CADD 11.10, Uncertain significance, not specified
- S22P (p.Ser22Pro), ExAC rs747378116, gnomAD rs747378116, REVEL 0.28, CADD 10.50
- L27V (p.Leu27Val), ExAC rs765349557, gnomAD rs765349557, REVEL 0.18, CADD 4.62
- I28L (p.Ile28Leu), Ensembl rs778241680, REVEL 0.22, CADD 0.02
- Q29R (p.Gln29Arg), Ensembl rs2127420526
- Q30* (p.Gln30Ter), rs879253824, ClinGen CA10575887, ClinVar RCV000236911, ClinVar RCV003556263, Pathogenic
- R31* (p.Arg31Ter), rs398123278, ClinGen CA249743, ClinVar RCV000078448, ClinVar RCV000175566, CADD 34.00, Pathogenic
- R31Q (p.Arg31Gln), rs1220835332, NCI-TCGA Cosmic COSV9922, TOPMed rs1220835332, gnomAD rs1220835332, REVEL 0.29, CADD 22.90, Variant assessed as somatic; moderate impact.
- L33P (p.Leu33Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- H34P (p.His34Pro), Ensembl rs1581836344
- H34Y (p.His34Tyr), NCI-TCGA Cosmic COSV9922, REVEL 0.30, CADD 18.50, Variant assessed as somatic; moderate impact.
- Q35* (p.Gln35Ter), rs1356455272, ClinGen CA364405751, ClinVar RCV003555285, ClinVar RCV005622244, CADD 36.00, Pathogenic
- Q37* (p.Gln37Ter), rs1487859107, ClinGen CA364405725, ClinVar RCV001091105, TOPMed rs1487859107, CADD 35.00, Pathogenic
- P38S (p.Pro38Ser), TOPMed rs1037540750, gnomAD rs1037540750, REVEL 0.39, CADD 21.50, Uncertain significance, not specified
- L39V (p.Leu39Val), TOPMed rs1767779186, gnomAD rs1767779186, REVEL 0.48, CADD 23.20
- H40L (p.His40Leu), gnomAD rs1223547181, REVEL 0.61, CADD 24.00
- H40Y (p.His40Tyr), rs774766479, Ensembl rs774766479, REVEL 0.63, CADD 23.10, Variant assessed as somatic; moderate impact.
- P41R (p.Pro41Arg), TOPMed rs1371693978, gnomAD rs1371693978, REVEL 0.64, CADD 26.70
- E42K (p.Glu42Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- W43* (p.Trp43Ter), rs2481350851, ClinGen CA364405659, ClinVar RCV002711771, Pathogenic
- A44T (p.Ala44Thr), gnomAD rs1475474686, REVEL 0.45, CADD 21.70
- A45S (p.Ala45Ser), TOPMed rs1251816896, gnomAD rs1251816896, REVEL 0.30, CADD 18.70
- A45T (p.Ala45Thr), NCI-TCGA Cosmic COSV5127, TOPMed rs1251816896, gnomAD rs1251816896, Uncertain significance, not specified
- L46Q (p.Leu46Gln), TOPMed rs1767778256
- K48E (p.Lys48Glu), gnomAD rs1277361146, REVEL 0.36, CADD 20.30
- K49N (p.Lys49Asn), NCI-TCGA TCGA novel, REVEL 0.39, CADD 21.60, Variant assessed as somatic; moderate impact.
- K49R (p.Lys49Arg), TOPMed rs1438206722, gnomAD rs1438206722, REVEL 0.39, CADD 22.70
- K49S (p.Lys49Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q50A (p.Gln50Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q50H (p.Gln50His), rs368296765, ClinGen CA3847177, ClinVar RCV002890661, ESP rs368296765, REVEL 0.58, CADD 21.00, Uncertain significance
- K52R (p.Lys52Arg), Ensembl rs1767777883, REVEL 0.39, CADD 22.70, Uncertain significance, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency
- K54* (p.Lys54Ter), rs1554161054, ClinGen CA364405547, ClinVar RCV000551650, ClinVar RCV001376569, CADD 37.00, Pathogenic
- K54R (p.Lys54Arg), rs559152765, ClinGen CA3847176, ClinVar RCV001298109, ClinVar RCV001830147, REVEL 0.35, CADD 22.60, Uncertain significance, not specified; not provided; Methylmalonic aciduria due to methylmalonyl-CoA mut
- N55K (p.Asn55Lys), rs483352780, ClinGen CA235520, ClinVar RCV000162230, TOPMed rs483352780, MutPred 0.46, not provided
- P56S (p.Pro56Ser), TOPMed rs1581836281, REVEL 0.54, CADD 20.80
- D58A (p.Asp58Ala), ExAC rs775206518, gnomAD rs775206518, REVEL 0.38, CADD 22.30
- D58Y (p.Asp58Tyr), TOPMed rs1767777380
- L59R (p.Leu59Arg), ExAC rs759122913, gnomAD rs759122913, REVEL 0.77, CADD 23.90
- L59V (p.Leu59Val), ExAC rs767154952, TOPMed rs767154952, gnomAD rs767154952, REVEL 0.58, CADD 18.50
- I60L (p.Ile60Leu), Ensembl rs756504816, REVEL 0.46, CADD 17.70
- I60T (p.Ile60Thr), rs770382069, ClinGen CA3847171, ClinVar RCV001885638, ExAC rs770382069, REVEL 0.49, CADD 15.50, Uncertain significance, not provided
- W61* (p.Trp61Ter), ExAC rs748832610, gnomAD rs748832610, CADD 36.00
- W61C (p.Trp61Cys), rs748832610, ClinGen CA364405467, ClinVar RCV003991897, Uncertain significance, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- W61R (p.Trp61Arg), TOPMed rs1167151157, gnomAD rs1167151157, REVEL 0.86, CADD 23.10
- H62Y (p.His62Tyr), TOPMed rs868567905, gnomAD rs868567905, REVEL 0.43, CADD 23.20
- T63I (p.Thr63Ile), rs1767776360, ClinGen CA364405445, ClinVar RCV001250103, TOPMed rs1767776360, REVEL 0.98, CADD 25.60, Uncertain significance, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- T63N (p.Thr63Asn), TOPMed rs1767776360, gnomAD rs1767776360, REVEL 0.94, CADD 25.00, Uncertain significance
- T63P (p.Thr63Pro), TOPMed rs1767776472, gnomAD rs1767776472, REVEL 0.99, CADD 26.00
- P64L (p.Pro64Leu), rs575038087, ClinGen CA3847168, ClinVar RCV000626275, ClinVar RCV002529786, REVEL 0.78, CADD 22.70, Uncertain significance, not specified; not provided; Methylmalonic aciduria due to methylmalonyl-CoA mut
- E65K (p.Glu65Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G66R (p.Gly66Arg), rs780214259, ClinGen CA3847166, ClinVar RCV004475008, ClinVar RCV005610671, REVEL 0.87, CADD 23.00, Uncertain significance, not specified
- I67S (p.Ile67Ser), ExAC rs772575390, gnomAD rs772575390
- I67V (p.Ile67Val), 1000Genomes rs540830529, REVEL 0.42, CADD 17.20
- I69M (p.Ile69Met), rs757381606, ClinGen CA3847162, ClinVar RCV004475084, ExAC rs757381606, REVEL 0.61, CADD 18.50, Uncertain significance, not specified
- I69V (p.Ile69Val), rs115923556, ClinGen CA3847163, ClinVar RCV000223962, ClinVar RCV001085527, REVEL 0.54, CADD 12.60, Conflicting interpretations, not specified; not provided; Methylmalonic aciduria due to methylmalonyl-CoA mut
- P71L (p.Pro71Leu), TOPMed rs1767774959, REVEL 0.95, CADD 25.40
- L72F (p.Leu72Phe), gnomAD rs1341884213, REVEL 0.53, CADD 4.17, Likely benign
- L72S (p.Leu72Ser), rs753913987, ClinGen CA3847160, ClinVar RCV002630640, ExAC rs753913987, REVEL 0.78, CADD 23.20, Uncertain significance
- Y73C (p.Tyr73Cys), TOPMed rs1320622655, gnomAD rs1320622655, REVEL 0.99, CADD 25.60
- S74A (p.Ser74Ala), ExAC rs777753506, gnomAD rs777753506, REVEL 0.52, CADD 22.70, Uncertain significance, not specified
- K75E (p.Lys75Glu), gnomAD rs1343160225, REVEL 0.32, CADD 16.50
- K75R (p.Lys75Arg), Ensembl rs1581836148
- R76G (p.Arg76Gly), ExAC rs752686314, gnomAD rs752686314, REVEL 0.28, CADD 14.90
- R76K (p.Arg76Lys), rs1252414363, ClinGen CA364405286, ClinVar RCV001315666, ClinVar RCV001835563, REVEL 0.23, CADD 11.10, Uncertain significance, not specified; not provided; Methylmalonic aciduria due to methylmalonyl-CoA mut
- R76T (p.Arg76Thr), TOPMed rs1252414363, gnomAD rs1252414363, Uncertain significance
- D77G (p.Asp77Gly), TOPMed rs915557587, REVEL 0.96, CADD 26.30
- D77V (p.Asp77Val), TOPMed rs915557587, REVEL 0.92, CADD 25.20
- T78A (p.Thr78Ala), gnomAD rs1414898553, REVEL 0.38, CADD 20.20
- M79L (p.Met79Leu), ExAC rs751177187, TOPMed rs751177187, gnomAD rs751177187, Uncertain significance
- M79T (p.Met79Thr), gnomAD rs1478816235, REVEL 0.31, CADD 0.33
- M79V (p.Met79Val), rs751177187, ClinGen CA3847154, ClinVar RCV001329131, ExAC rs751177187, REVEL 0.32, CADD 4.45, Uncertain significance, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- L81I (p.Leu81Ile), rs150841850, ClinGen CA364405234, ClinVar RCV001835136, ClinVar RCV002564040, REVEL 0.27, CADD 13.90, Uncertain significance, not provided
- P82R (p.Pro82Arg), ExAC rs766062848, gnomAD rs766062848, REVEL 0.53, CADD 21.90
- E83D (p.Glu83Asp), TOPMed rs1767772916, REVEL 0.33, CADD 14.30
- E83V (p.Glu83Val), TOPMed rs1254282153
- E84D (p.Glu84Asp), TOPMed rs1767772821
- E84K (p.Glu84Lys), NCI-TCGA Cosmic COSV1043, NCI-TCGA Cosmic COSV9922, REVEL 0.69, CADD 22.70, Variant assessed as somatic; moderate impact.
- L85F (p.Leu85Phe), ExAC rs762507663, TOPMed rs762507663, gnomAD rs762507663, REVEL 0.44, CADD 22.40
- L85V (p.Leu85Val), ExAC rs762507663, TOPMed rs762507663, gnomAD rs762507663, REVEL 0.44, CADD 20.60
- P86L (p.Pro86Leu), rs769348060, ClinGen CA3847150, ClinVar RCV000669290, ClinVar RCV001376596, REVEL 0.98, CADD 28.80, Pathogenic/Likely pathogenic, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency; MMUT
- P86R (p.Pro86Arg), rs769348060, ClinGen CA138801030, ClinVar RCV003665506, ExAC rs769348060, MutPred 0.93, Likely pathogenic, not provided
- P86S (p.Pro86Ser), ExAC rs772660572, gnomAD rs772660572, REVEL 0.95, CADD 24.50, Uncertain significance, not specified
- P86T (p.Pro86Thr), rs772660572, ClinGen CA364405168, ClinVar RCV003730978, ExAC rs772660572, REVEL 0.95, CADD 26.20, Likely pathogenic, not provided
- G87E (p.Gly87Glu), rs1554160986, ClinGen CA364405151, ClinVar RCV000674559, UniProt VAR 026593, MutPred 0.92, Likely pathogenic, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency
- V88M (p.Val88Met), rs776085460, ClinGen CA3847148, ClinVar RCV003087614, ExAC rs776085460, REVEL 0.25, CADD 14.10, Uncertain significance
- K89T (p.Lys89Thr), NCI-TCGA Cosmic COSV5127, Variant assessed as somatic; moderate impact.
- P90Q (p.Pro90Gln), TOPMed rs1767771853
- P90S (p.Pro90Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T92A (p.Thr92Ala), Ensembl rs1767771684
- R93C (p.Arg93Cys), rs746274670, ClinGen CA3847146, ClinVar RCV000669202, ClinVar RCV001815368, REVEL 0.92, CADD 29.30, Likely pathogenic, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency; Like
- R93H (p.Arg93His), rs121918251, ClinGen CA249728, ClinVar RCV000001957, ClinVar RCV000175568, REVEL 0.96, CADD 26.90, Pathogenic, Methylmalonic acidemia; Methylmalonic aciduria due to complete methylmalonyl-CoA
- R93S (p.Arg93Ser), rs746274670, ClinGen CA364405093, ClinVar RCV001029829, ClinVar RCV003541098, REVEL 0.95, CADD 26.40, Pathogenic, not provided
- G94R (p.Gly94Arg), rs727504022, ClinGen CA234291, ClinVar RCV000175567, ClinVar RCV001535925, REVEL 0.98, CADD 26.40, Pathogenic/Likely pathogenic, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency; Methylmalonic
- G94V (p.Gly94Val), rs535411418, ClinGen CA3847145, ClinVar RCV000814597, ClinVar RCV001091104, REVEL 0.99, CADD 25.60, Pathogenic, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency; not
- P95L (p.Pro95Leu), rs190834116, ClinGen CA3847144, ClinVar RCV000415260, ClinVar RCV002524669, REVEL 0.90, CADD 27.80, Uncertain significance, MMUT-related disorder; not specified; not provided
- P95R (p.Pro95Arg), rs190834116, ClinGen CA347886, ClinVar RCV000203360, UniProt VAR 026595, MutPred 0.88, not provided, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- Y96H (p.Tyr96His), NCI-TCGA Cosmic COSV5127, Variant assessed as somatic; moderate impact.
- T98A (p.Thr98Ala), ExAC rs754740382, TOPMed rs754740382, gnomAD rs754740382, REVEL 0.77, CADD 23.80, Uncertain significance
- T98P (p.Thr98Pro), rs754740382, ClinGen CA3847140, ClinVar RCV000817397, ExAC rs754740382, REVEL 0.92, CADD 27.40, Pathogenic, not provided
- M99T (p.Met99Thr), rs1767770379, ClinGen CA364405059, ClinVar RCV002561121, TOPMed rs1767770379, REVEL 0.95, CADD 25.90, Pathogenic, not provided
- M99V (p.Met99Val), rs1467385866, ClinGen CA364405063, ClinVar RCV000521248, ClinVar RCV004586758, REVEL 0.95, CADD 25.30, Conflicting interpretations, not provided; not specified
- Y100C (p.Tyr100Cys), rs864309735, ClinGen CA347866, ClinVar RCV000203328, ClinVar RCV001384466, REVEL 0.98, CADD 28.90, Pathogenic/Likely pathogenic, not provided; Methylmalonic acidemia
- T101A (p.Thr101Ala), NCI-TCGA Cosmic COSV5127, Variant assessed as somatic; moderate impact.
- T101P (p.Thr101Pro), Ensembl rs1581836032
- F102V (p.Phe102Val), TOPMed rs1767770117
- P104S (p.Pro104Ser), 1000Genomes rs537995137, ExAC rs537995137, gnomAD rs537995137, REVEL 0.90, CADD 26.90, Uncertain significance, not specified
- W105R (p.Trp105Arg), rs121918249, ClinGen CA249727, ClinVar RCV000001955, ClinVar RCV000203407, REVEL 0.89, CADD 29.30, Pathogenic, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency; Methylmalonic
- T106I (p.Thr106Ile), rs1561959708, ClinGen CA364405010, ClinVar RCV000722411, TOPMed rs1561959708, MutPred 0.65, Uncertain significance, not provided
- R108C (p.Arg108Cys), rs121918257, ClinGen CA249732, ClinVar RCV000001964, ClinVar RCV000203340, REVEL 0.96, CADD 29.80, Pathogenic, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency; not
- R108G (p.Arg108Gly), rs121918257, ClinGen CA364404999, ClinVar RCV002013072, UniProt VAR 026597, REVEL 0.97, CADD 27.30, Likely pathogenic, not provided
- R108H (p.Arg108His), rs483352778, ClinGen CA235522, ClinVar RCV000162231, ClinVar RCV000502227, REVEL 0.97, CADD 27.10, Pathogenic, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency; not
- R108L (p.Arg108Leu), rs483352778, ClinGen CA364404997, ClinVar RCV003575697, REVEL 0.97, CADD 26.70, Likely pathogenic, not provided
- Q109R (p.Gln109Arg), rs1461110052, UniProt VAR 023473, gnomAD rs1461110052, REVEL 0.98, CADD 27.30, Likely pathogenic, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency
- Y110* (p.Tyr110Ter), rs879253826, ClinGen CA10575885, ClinVar RCV000236434, ClinVar RCV001376599, CADD 36.00, Pathogenic, in MAMM
- Y110C (p.Tyr110Cys), rs796052005, ClinGen CA312775, ClinVar RCV000186053, ClinVar RCV001027998, MutPred 0.88, Pathogenic/Likely pathogenic, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency; not
- E117* (p.Glu117Ter), rs121918253, ClinGen CA115264, ClinVar RCV000001959, ClinVar RCV000670836, CADD 37.00, Pathogenic
- E117K (p.Glu117Lys), TOPMed rs121918253, REVEL 0.86, CADD 26.10, Pathogenic
- E118K (p.Glu118Lys), NCI-TCGA Cosmic COSV5127, Variant assessed as somatic; moderate impact.
- S119N (p.Ser119Asn), gnomAD rs1767768403, REVEL 0.87, CADD 25.10
- N120K (p.Asn120Lys), rs2481349847, ClinGen CA364404913, ClinVar RCV003843608, Likely pathogenic, not provided
- N120S (p.Asn120Ser), rs776108716, ClinGen CA3847135, ClinVar RCV001941413, ClinVar RCV002484720, REVEL 0.86, CADD 28.80, Uncertain significance, not provided; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- K121* (p.Lys121Ter), rs1554160919, ClinGen CA658823265, ClinVar RCV000674054, Pathogenic
- K121T (p.Lys121Thr), rs1314720800, NCI-TCGA Cosmic COSV5127, TOPMed rs1314720800, gnomAD rs1314720800, REVEL 0.69, CADD 23.10, Uncertain significance, not specified
- F122I (p.Phe122Ile), TOPMed rs1767768023, gnomAD rs1767768023, REVEL 0.91, CADD 27.10
- F122L (p.Phe122Leu), rs368780480, ClinGen CA3847133, ClinVar RCV004475278, ESP rs368780480, REVEL 0.83, CADD 25.80, Uncertain significance, not specified
- Y123C (p.Tyr123Cys), gnomAD rs1312660252, REVEL 0.92, CADD 29.90
- K124E (p.Lys124Glu), ExAC rs774922902, gnomAD rs774922902, REVEL 0.78, CADD 27.40
- D125N (p.Asp125Asn), gnomAD rs1397473284, REVEL 0.52, CADD 23.90
- N126D (p.Asn126Asp), Ensembl rs1205928643
- N126K (p.Asn126Lys), rs879253827, ClinGen CA10575884, ClinVar RCV000237003, UniProt VAR 077210, MutPred 0.78, Pathogenic, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- I127V (p.Ile127Val), gnomAD rs1767767422, REVEL 0.68, CADD 23.20
- K128N (p.Lys128Asn), NCI-TCGA Cosmic COSV5127, gnomAD rs1767767152, Variant assessed as somatic; moderate impact.
- K128R (p.Lys128Arg), rs1265485739, ClinGen CA364404857, ClinVar RCV004475312, REVEL 0.52, CADD 24.40, Uncertain significance, not specified
- K128T (p.Lys128Thr), TOPMed rs1265485739
- A129V (p.Ala129Val), gnomAD rs1180569537, REVEL 0.88, CADD 32.00, Uncertain significance, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency
- Q131H (p.Gln131His), rs145682249, ClinGen CA364404820, ClinVar RCV002975751, Uncertain significance
- Q131L (p.Gln131Leu), ExAC rs760054029, gnomAD rs760054029, REVEL 0.97, CADD 27.30
- Q132* (p.Gln132Ter), rs1554160743, ClinGen CA364404817, ClinVar RCV001380755, ClinVar RCV001829801, CADD 39.00, Pathogenic
- Q132L (p.Gln132Leu), rs766605891, ClinGen CA364404815, ClinVar RCV001297506, ExAC rs766605891, REVEL 0.88, CADD 24.20, Uncertain significance, not provided
- Q132R (p.Gln132Arg), ExAC rs766605891, gnomAD rs766605891, REVEL 0.64, CADD 23.60, Uncertain significance
- G133* (p.Gly133Ter), rs879253828, ClinGen CA364404811, ClinVar RCV001264283, ClinVar RCV003660880, MutPred 0.92, Pathogenic, in MAMM
- G133E (p.Gly133Glu), rs2127420078, ClinGen CA364404810, ClinVar RCV003324328, Ensembl rs2127420078, Uncertain significance, not specified
- G133R (p.Gly133Arg), rs879253828, ClinGen CA10575883, ClinVar RCV000235708, UniProt VAR 077211, REVEL 0.91, CADD 26.70, Pathogenic, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
- G133V (p.Gly133Val), rs2127420078, ClinGen CA364404808, ClinVar RCV003324327, MutPred 0.93, Uncertain significance, not specified
Public MMUT analysis runs
- MMUT analysis run — MMUT (1,295 variants) — completed 2026-08-21